E
EGBOT
Guest
ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients
Source: ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients
HTML:
ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.
Source: ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients